Kyriaco at a 20 cents share price it’s a 32 million dollar valuation lol. Peers in the TBI space are already trading multiples of this on safety north of 100 million dollars. It’s got a lot to rerate now it has the potential to overtake a 4 billion dollar market on cardiovascular health.
Ann: NYR Completes Safety Studies Ahead of Phase I Clinical Trial, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $73.82M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 35.5¢ | 31.0¢ | $213.4K | 643.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 29064 | 2 |
View Market Depth
| Last trade - 15.59pm 23/07/2025 (20 minute delay) ? |
| NYR (ASX) Chart |